market access teams

2.26.2014 Account Strategy for Payer Organizations

Provide a Framework for New Product Planning Groups to Influence Clinical Trials

By Jacob Presson, Research Analyst A common theme running through a lot of what we at Cutting Edge Information learn while conducting research on the pharmaceutical industry is the need for more consistent and productive communication between internal...
 

1.8.2014 Clinical Development

Drug Safety Data and HEOR Driving Clinical Trial Costs and Time

By Ryan McGuire, Research Team Leader The healthcare marketplace has seen seismic shifts over the past five years.  Austerity measures have strained the reimbursement climate in many EU countries and driven government payers to scrutinize every...
 

11.14.2013 Managed Care Liaison / HOL

A Method to the Madness: Managed Markets Account Managers

By Jacob Presson, Research Analyst As payers demand ever-increasing evidence of product efficacy and cost effectiveness from the pharmaceutical industry, managing relationships with them is growing in strategic importance.  As a result, account...
 

11.7.2013 Health Economics and Outcomes Research (HEOR)

HEORs and Tails: Why Is Staffing Market Access Teams So Difficult?

By Christie Shilling, Research Analyst Pharmaceutical market access teams hold a wide range of responsibilities and, as such, require employees with a variety of knowledge and skills.  Organizations that create a well-rounded market access team...
 

9.5.2013 Market Access

Market Access Budgets Rebound After 2012 Patent Cliff

By Natalie DeMasi, Research Analyst In 2012, many key drugs in the US fell off the patent cliff and lost their market exclusivity.  As US pharmaceutical companies watched these products meet their fates, they tried their best to mitigate the damage. ...
 

9.4.2013 Managed Care Liaison / HOL

Ideal Criteria for Finding Top-Notch Health Outcomes Liaisons

By Nicole May, Research Analyst With the expanding emphasis on building payer relationships and demonstrating product value, health outcomes liaison and managed care liaison teams are more important than ever.  The first step to building a strong...
 

8.13.2013 Managed Care Liaison / HOL

Want Top Formulary Postions? You’ll Need a Well-Armed Payer Liaison Team

By Nicole May, Research Analyst Payer meetings are crucial to drug success.  Payer liaison teams, whether they consist of health outcomes liaisons (HOL), managed care liaisons (MCL), or any other medical/economic expert team, must convince payers...
 

8.6.2013 Account Strategy for Government

Government Affairs Teams: Promoting Patient Education and Access

By Sarah Ray, Research Analyst When it comes to healthcare in the US, the 10th annual National Healthcare Disparities Report — released earlier this year — shows that the quality of patient care is improving.  Yet when it comes to patient access,...
 

8.1.2013 Health Economics and Outcomes Research (HEOR)

Market Access Success: It’s All About Timing

By Natalie DeMasi, Research Analyst A good cook doesn’t just throw together all of the ingredients and hope everything turns out okay. Take a grilled cheese sandwich, for example. You melt butter before putting bread in a skillet, and you don’t...
 

7.3.2013 Account Strategy for Payer Organizations

Pharma Companies Make Market Access a Top Priority, With or Without Dedicated Departments

By Natalie DeMasi, Research Analyst As most companies’ main ambassadors to payers, market access groups lead the efforts to earn reimbursement for their organizations’ brands.  These groups specialize in working directly with payers — discussing...